||Roger S. McIntyre, MD, FRCPC
University of Toronto
University Health Network
Chairman and Executive Director, Brain and Cognition, Depression and Bipolar Support Alliance (DBSA)
Clinical Professor, Department of Psychiatry and Neurosciences
University of California School of Medicine
Dr. Roger McIntyre is currently a Professor of Psychiatry and
Pharmacology at the University of Toronto and Head of the Mood
Disorders Psychopharmacology Unit at the University Health Network,
Toronto, Canada. Dr. McIntyre is also Executive Director of the Brain and
Cognition Discovery Foundation in Toronto, Canada. He is Director as
well as Co-Chair of the Scientific Advisory Board of the Depression and
Bipolar Support Alliance (DBSA) from Chicago, Illinois, USA. Dr.
McIntyre also serves as Professor and Nanshan Scholar at Guangzhou
Medical University, and Adjunct Professor at the College of Medicine at
Korea University. Additionally, Dr. McIntyre is also Clinical Professor at
the State University of New York (SUNY) Upstate Medical University,
Syracuse, New York, USA and Clinical Professor in the Department of
Psychiatry and Neurosciences at the University of California School of
Medicine. Dr. McIntyre was named by Clarivate Analytics as one of "The
World's Most Influential Scientific Minds" from 2014 through 2019. This
distinction is given by publishing the largest number of articles that rank
among those most frequently cited by researchers globally in 21 broad
fields of science and social science during the previous decade. Dr.
McIntyre is also the President and CEO of Champignon.
Dr. McIntyre is involved in multiple research endeavours which primarily
aim to characterize the association between mood disorders, notably
cognitive function and medical comorbidity. His work broadly aims to
characterize the underlying causes of cognitive impairment in
individuals with mood disorders and their impact on workplace
functioning. This body of work has provided a platform for identifying
novel molecular targets to treat and prevent mood disorders and
accompanying cognitive impairment.
Dr. McIntyre is extensively involved in medical education. He is a highly
sought-after speaker at both national and international meetings. He
has received several teaching awards from the University of Toronto,
Department of Psychiatry and has been a recipient of the joint Canadian
Psychiatric Association (CPA) / Council of Psychiatric Continuing
Education Award for the Most Outstanding Continuing Education Activity
in Psychiatry in Canada.
Dr. McIntyre was the lead author for the Florida Best Practice
Psychotherapeutic Medication Guidelines for Adults with Major
Depressive Disorder and Bipolar Disorder. He has also contributed to the
Canadian Network for Mood and Anxiety (CANMAT) guidelines for the
treatment of Depressive Disorders and Bipolar Disorders. Dr. McIntyre
has published more than 600 articles/manuscripts and has edited
and/or co-edited several textbooks on mood disorders.
Dr. McIntyre completed his medical degree at Dalhousie University. He
received his Psychiatry residency training and Fellowship in Psychiatric
Pharmacology at the University of Toronto.